Choi, C
For biologics, estimate biosimilar entry timing based on: 351(k) application filing date and development timeline, likely reference product exclusivity end date, Patent Dance status, and the commercial resources of the biosimilar developer
Clinical trials have shown that gastrointestinal issues are the most frequently reported side effects, with 15.8% of patients experiencing nausea, 8.5% experiencing diarrhea, and 7.3% reporting abdominal pain [17]
Beverage giants had already been innovating with smaller soda formats to reduce calories (see for example 7.5oz mini cans from Coca-Cola, Sprite and Fanta): expect to see more miniature formats on shelves.
Conclusion: Ozempic and Breastfeeding When it comes to Ozempic and breastfeeding, the research is limited but promising
Preparation of an activatable benzothiadiazole-based nanoprobe for multispectral optoacoustic and NIR-II fluorescence dual-mode imaging of liver injury